Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein

Cancer Biology and Therapy

Volumn 2, Issue 4, 2003, Pages 372-380

  Criswell, Tracy ^a,b   Klokov, Dmitry ^a   Beman, Meghan ^a   Lavik, J P ^a   Boothman, David A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Program in Molecular and Cellular Basis of Disease   (United States)

Author keywords

Clusterin; Ionizing radiation; p53

Indexed keywords

ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CHAPERONE; CLU PROTEIN, HUMAN; CLUSTERIN; COMPLEMENT INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; GLYCOPROTEIN; MESSENGER RNA; ONCOPROTEIN; PROTEIN P53; REPRESSOR PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BREAST TUMOR; COLON TUMOR; CYTOPLASM; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GAMMA RADIATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; PROSTATE TUMOR; RADIATION EXPOSURE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CLUSTERIN; COLONIC NEOPLASMS; COMPLEMENT INACTIVATOR PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOPLASM; DNA DAMAGE; FEMALE; GAMMA RAYS; GLYCOPROTEINS; HUMANS; MALE; MOLECULAR CHAPERONES; NEOPLASM PROTEINS; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2342566706     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.2.4.430     Document Type: Article

References (58)

1. Leskov KS, Klokov DY, Li J, Kinsella TJ and Boothman DA.Synthesis and functional analyses of nuclear clusterin, a cell death protein.J Biol Chem 2003; 278:11590-600. (Pubitemid 36792721)
2. Guenette RS, Corbeil HB, Leger J, Wong K, Mezl V, Mooibroek M, et al.Induction of gene expression during involution of the lactating mammary gland of the rat.J Mol Endocrinol 1994; 12:47-60.
3. McDonald JF and Nelsestuen GL.Potent inhibition of terminal complement assembly by clusterin: Characterization of its impact on c9 polymerization. Biochemistry 1997; 36:7464-73.
4. Murphy BF, Saunders JR, O'Bryan MK, Kirszbaum L, Walker ID and d'Apice AJ.Sp-40,40 is an inhibitor of c5b-6-initiated haemolysis.Int Immunol 1989; 1:551-4.
5. Gelissen IC, Hochgrebe T, Wilson MR, Easterbrook-Smith SB, Jessup W, Dean RT, et al.Apolipoprotein j (clusterin) induces cholesterol export from macrophage-foam cells: A potential anti-atherogenic function?Biochem J 1998; 331:231-7.
6. Jenne DE, Lowin B, Peitsch MC, Bottcher A, Schmitz G and Tschopp J.Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein a-i in human plasma.J Biol Chem 1991; 266:11030-6.
7. Polihronis M, Paizis K, Carter G, Sedal L and Murphy B.Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology.J Neurol Sci 1993; 115:230-3.
8. Urbich C, Fritzenwanger M, Zeiher AM and Dimmeler S.Laminar shear stress upregulates the complement-inhibitory protein clusterin : A novel potent defense mechanism against complement-induced endothelial cell activation.Circulation 2000; 101:352-5.
9. Ishikawa Y, Akasaka Y, Ishii T, Komiyama K, Masuda S, Asuwa N, et al.Distribution and synthesis of apolipoprotein j in the atherosclerotic aorta.Arterioscler Thromb Vasc Biol 1998; 18:665-72.
10. Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B and Ghiso J.Apolipoprotein j (clusterin) and alzheimer's disease.Microsc Res Tech 2000; 50:305-315.
11. DeMattos RB, Brendza RP, Heuser JE, Kierson M, Cirrito JR, Fryer J, et al.Purification and characterization of astrocyte-secreted apolipoprotein e and j-containing lipoproteins from wild-type and human apoe transgenic mice.Neurochem Int 2001; 39:415-25.
12. Lidstrom AM, Bogdanovic N, Hesse C, Volkman I, Davidsson P and Blennow K.Clusterin (apolipoprotein j) protein levels are increased in hippocampus and in frontal cortex in alzheimer's disease.Exp Neurol 1998; 154:511-21.
13. Boothman DA, Bouvard I and Hughes EN.Identification and characterization of x-ray-induced proteins in human cells.Cancer Res 1989; 49:2871-8.
14. Yang CR, Yeh S, Leskov K, Odegaard E, Hsu HL, Chang C, et al.Isolation of ku70-binding proteins (kubs).Nucleic Acids Res 1999; 27:2165-74.
15. Yang CR, Leskov K, Hosley-Eberlein K, Criswell T, Pink JJ, Kinsella TJ, et al.Nuclear clusterin/ xip8, an x-ray-induced ku70-binding protein that signals cell death.Proc Natl Acad Sci U S A 2000; 97:5907-12.
16. Hough CD, Cho KR, Zonderman AB, Schwartz DR and Morin PJ.Coordinately up-regulated genes in ovarian cancer.Cancer Res 2001; 61:3869-76.
17. Steinberg J, Oyasu R, Lang S, Sintich S, Rademaker A, Lee C, et al.Intracellular levels of sgp-2 (clusterin) correlate with tumor grade in prostate cancer.Clin Cancer Res 1997; 3:1707-11.
18. Miyake H, Nelson C, Rennie PS and Gleave ME.Acquisition of chemoresistant phenotype by overexpression of the antiapoptotic gene testosterone-repressed prostate message-2 in prostate cancer xenograft models.Cancer Res 2000; 60:2547-54.
19. Miyake H, Hara I, Kamidono S, Gleave ME and Eto H.Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression.Oncol Rep 2003; 10:469-73.
20. Miyake H, Hara I, Kamidono S and Gleave ME.Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.Clin Cancer Res 2001; 7:4245-52.
21. Miyake H, Chi KN and Gleave ME.Antisense trpm-2 oligodeoxynucleotides chemosensitize human androgen-independent pc-3 prostate cancer cells both in vitro and in vivo.Clin Cancer Res 2000; 6:1655-63.
22. Gleave ME, Miyake H, Zellweger T, Chi K, July L, Nelson C, et al.Use of antisense oligonucleotides targeting the antiapoptotic gene, clusterin/testosterone-repressed prostate message 2, to enhance androgen sensitivity and chemosensitivity in prostate cancer.Urology 2001; 58:39-49.
23. Zellweger T, Miyake H, July LV, Akbari M, Kiyama S and Gleave ME.Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.Neoplasia 2001; 3:360-7.
24. Levine AJ, Momand J and Finlay CA.The p53 tumour suppressor gene.Nature 1991; 351:453-6.
25. Canman CE, Chen CY, Lee MH and Kastan MB.DNA damage responses: P53 induction, cell cycle perturbations, and apoptosis.Cold Spring Harb Symp Quant Biol 1994; 59:277-86.
26. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, et al.P53-mediated cell death: Relationship to cell cycle control. Mol Cell Biol 1993; 13:1415-23. (Pubitemid 23068077)
27. Kastan MB, Canman CE and Leonard CJ.P53, cell cycle control and apoptosis: Implications for cancer.Cancer Metastasis Rev 1995; 14:3-15.
28. Roperch JP, Alvaro V, Prieur S, Tuynder M, Nemani M, Lethrosne F, et al.Inhibition of presenilin 1 expression is promoted by p53 and p21waf-1 and results in apoptosis and tumor suppression.Nat Med 1998; 4:835-8.
29. Agoff SN, Hou J, Linzer DI and Wu B.Regulation of the human hsp70 promoter by p53.Science 1993; 259:84-7.
30. Yamamoto M, Yoshida M, Ono K, Fujita T, Ohtani-Fujita N, Sakai T, et al.Effect of tumor suppressors on cell cycle-regulatory genes: Rb suppresses p34cdc2 expression and normal p53 suppresses cyclin a expression.Exp Cell Res 1994; 210:94-101.
31. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mossner J, et al.The tumour suppressor protein p53 can repress transcription of cyclin b.Nucleic Acids Res 2000; 28:4410-8.
32. Taylor WR, Schonthal AH, Galante J and Stark GR.P130/e2f4 binds to and represses the cdc2 promoter in response to p53.J Biol Chem 2001; 276:1998-2006.
33. Bandyk MG, Sawczuk IS, Olsson CA, Katz AE and Buttyan R.Characterization of the products of a gene expressed during androgen- programmed cell death and their potential use as a marker of urogenital injury.J Urol 1990; 143:407-13.
34. Akakura K, Bruchovsky N, Rennie PS, Coldman AJ, Goldenberg SL, Tenniswood M, et al.Effects of intermittent androgen suppression on the stem cell composition and the expression of the trpm-2 (clusterin) gene in the shionogi carcinoma.J Steroid Biochem Mol Biol 1996; 59:501-11. (Pubitemid 27037917)
35. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al.Requirement for p53 and p21 to sustain g2 arrest after DNA damage.Science 1998; 282:1497-501.
36. Pink JJ, Wuerzberger-Davis S, Tagliarino C, Planchon SM, Yang X, Froelich CJ, et al.Activation of a cysteine protease in mcf-7 and t47d breast cancer cells during beta-lapachone-mediated apoptosis.Exp Cell Res 2000; 255:144-55.
37. Boothman DA, Meyers M, Fukunaga N and Lee SW.Isolation of x-ray-inducible transcripts from radioresistant human melanoma cells.Proc Natl Acad Sci U S A 1993; 90:7200-4.
38. Agani FH, Puchowicz M, Chavez JC, Pichiule P and LaManna J.Role of nitric oxide in the regulation of hif-1alpha expression during hypoxia.Am J Physiol Cell Physiol 2002; 283:C178-86.
39. Wuerzberger SM, Pink JJ, Planchon SM, Byers KL, Bornmann WG and Boothman DA.Induction of apoptosis in mcf-7:Ws8 breast cancer cells by beta-lapachone.Cancer Res 1998; 58:1876-85.
40. Bach UC, Baiersdorfer M, Klock G, Cattaruzza M, Post A and Koch-Brandt C.Apoptotic cell debris and phosphatidylserine-containing lipid vesicles induce apolipoprotein j (clusterin) gene expression in vital fibroblasts.Exp Cell Res 2001; 265:11-20. (Pubitemid 32989059)
41. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D and Boothman DA.Nad(p)h:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity.J Biol Chem 2000; 275:5416-24.
42. Scheffner M, Werness BA, Huibregtse JM, Levine AJ and Howley PM.The e6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.Cell 1990; 63:1129-36.
43. Davis TW, Wilson-Van Patten C, Meyers M, Kunugi KA, Cuthill S, Reznikoff C, et al.Defective expression of the DNA mismatch repair protein, mlh1, alters g2-m cell cycle checkpoint arrest following ionizing radiation.Cancer Res 1998; 58:767-78.
44. Bettuzzi S, Astancolle S, Guidetti G, Moretti M, Tiozzo R and Corti A.Clusterin (sgp-2) gene expression is cell cycle dependent in normal human dermal fibroblasts.FEBS Lett 1999; 448:297-300.
45. Meyers M, Theodosiou M, Acharya S, Odegaard E, Wilson T, Lewis JE, et al.Cell cycle regulation of the human DNA mismatch repair genes hmsh2, hmlh1, and hpms2.Cancer Res 1997; 57:206-8. (Pubitemid 27036594)
46. Meyers M, Wagner MW, Hwang HS, Kinsella TJ and Boothman DA.Role of the hmlh1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.Cancer Res 2001; 61:5193-201.
47. Tagliarino C, Pink JJ, Dubyak GR, Nieminen AL and Boothman DA.Calcium is a key signaling molecule in beta-lapachone-mediated cell death.J Biol Chem 2001; 276:19150-9.
48. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM and Latchman DS.P53 suppresses the activation of the bcl-2 promoter by the brn-3a pou family transcription factor.J Biol Chem 1999; 274:15237-44.
49. Lee KC, Crowe AJ and Barton MC.P53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.Mol Cell Biol 1999; 19:1279-88.
50. Ori A, Zauberman A, Doitsh G, Paran N, Oren M and Shaul Y.P53 binds and represses the hbv enhancer: An adjacent enhancer element can reverse the transcription effect of p53.Embo J 1998; 17:544-53.
51. Kanaya T, Kyo S, Hamada K, Takakura M, Kitagawa Y, Harada H, et al.Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.Clin Cancer Res 2000; 6:1239-47.
52. Ohlsson C, Kley N, Werner H and LeRoith D.P53 regulates insulin-like growth factor-i (igf-i) receptor expression and igf-i-induced tyrosine phosphorylation in an osteosarcoma cell line: Interaction between p53 and sp1.Endocrinology 1998; 139:1101-7.
53. Sun Y, Wenger L, Rutter JL, Brinckerhoff CE and Cheung HS.P53 down-regulates human matrix metalloproteinase-1 (collagenase-1) gene expression.J Biol Chem 1999; 274:11535-40.
54. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A and Dannenberg AJ.Inhibition of cyclooxygenase-2 gene expression by p53.J Biol Chem 1999; 274:10911-5.
55. Yun J, Chae HD, Choy HE, Chung J, Yoo HS, Han MH, et al.P53 negatively regulates cdc2 transcription via the ccaat-binding nf-y transcription factor.J Biol Chem 1999; 274:29677-82.
56. Kubicka S, Kuhnel F, Zender L, Rudolph KL, Plumpe J, Manns M, et al.P53 represses caat enhancer-binding protein (c/ebp)-dependent transcription of the albumin gene. A molecular mechanism involved in viral liver infection with implications for hepatocarcinogenesis. J Biol Chem 1999; 274:32137-44.
57. Martin DW, Munoz RM, Subler MA and Deb S.P53 binds to the tata-binding protein-tata complex.J Biol Chem 1993; 268:13062-7.
58. Johnson RA, Ince TA and Scotto KW.Transcriptional repression by p53 through direct binding to a novel DNA element.J Biol Chem 2001; 276:27716-20.